CSI Market
Sign In | Register

Molecular Templates Inc (MTEM) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access MTEM Annual Cash Flow →
Cash flow data covering Molecular Templates Inc–Jun 30 2023 offers a view into how Jun 30 2024's cash position has developed alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2024)
6 Months 		(Mar 31 2024) (Dec 31 2023) (Sep 30 2023) (Jun 30 2023)
Operating Activities
Income-7.53
Depreciation & amortization2.17
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense-8.97
Impairment of Long-Lived Assets to be Disposed of0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation1.81
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Change In Common Stock Warrant Value-
Increase Decrease In Accrued Clinical And Development Expenses-
Increase Decrease In Deferred Rent-
Cumulative Change In Accounting Principle-
Noncash Deferred Stock Based Compensation-
Gain Loss On Derivative Instruments Net Pretax-
Interest Costs Capitalized Adjustment-
Increase Decrease In Grants Revenue Receivable-0.55
Increase Decrease In Operating Lease Right Of Use Assets Non Current-
Increase Decrease In Other Noncurrent Liabilities Related Parties-
Increase Decrease In Contract With Customer Liability-
Impairment And Loss On Fixed Assets And Intangibles-
Interest Expense Long Term Debt-
Debt Instrument Increase Accrued Interest-0.17
Fair Value Adjustment Contingent Value Right-0.65
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable, Related Parties0.00
Increase (Decrease) in Accounts Payable1.25
Increase (Decrease) in Accrued Liabilities-2.01
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense1.41
Other Working Capital2.13
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-0.17
Discontinued operations0.00
Net Cash flow from Operating Activities-11.10
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities0.00
Payments to Acquire Marketable Securities0.00
Real Estate Investments0.00
Issuance Of Promissory Note To Molecular Templates-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Cash Acquired from Acquisition0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock8.62
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-12.84
Deferred Offering Cost-
Proceeds From Issuance Of Long Term Debt And Warrants Net-
Finance Lease Principal Payments-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations12.84
Payments Of Capital And Financing Lease Obligations-
Fees Paid On Loan Modification-
Net Proceeds From Issuance Of Private Placement-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities8.62
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-11.10
Total Cash Flow-2.49
4 historic quarters locked

Sign in to unlock the full Molecular Templates Inc cash flow history.

Sign In Create Free Account

About Molecular Templates Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001558370-24-012257

Figures are derived from filed reports and may be restated. Historical data is subject to revision.